Jenna Loehmann, APRN

Jenna Loehmann practices at Ascension St. Vincent's Riverside in Jacksonville, Florida, part of Ascension Health Alliance.

Jenna Loehmann's NPI, 1407303225, was assigned on September 9, 2016. Jenna Loehmann holds Florida license APRN9324749.

Jenna Loehmann's primary practice is Ascension St. Vincent's Riverside, at 1 Shircliff Way, Jacksonville, FL 32204 in Duval County. The practice phone is (904) 308-7300.

Jenna Loehmann's primary practice is Ascension St. Vincent's Riverside in Jacksonville, Florida, part of Ascension Health Alliance. The medical group on file is Northeast Florida Endocrine and Diabetes Associates. Dmand AI also links Jenna Loehmann to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jenna Loehmann practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Jenna Loehmann's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Jenna Loehmann is licensed in Florida.

Dmand AI lists diabetic emergency among the conditions Jenna Loehmann treats.

CMS data shows 990 Medicare services from Jenna Loehmann across 4 procedure codes in 2024, for 389 Medicare patients. Medicare paid $56,295 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 389 Medicare patients who saw Jenna Loehmann in 2024. The largest group is 75 to 84, with 147 patients. 75% of them have diabetes, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 2.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jenna Loehmann's median patient age at 67, with 50% women.

In 2024, Jenna Loehmann wrote 208 Medicare Part D claims for 114 patients. 8% of them were for generic drugs. CMS names the drug for 113 of them, across 5 drugs with 11 or more claims each, at $55,061 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Jenna Loehmann for performance year 2024, reported through an alternative payment model (APM). Jenna Loehmann accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 55 general payments to Jenna Loehmann from 11 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $806.